Senti Biosciences, Inc. (SNTI)
NASDAQ: SNTI · Real-Time Price · USD
1.900
+0.120 (6.74%)
At close: Oct 9, 2025, 4:00 PM EDT
1.900
0.00 (0.00%)
Pre-market: Oct 10, 2025, 5:47 AM EDT

Revenue by Product

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
FY 2023FY 2022FY 2021
Period Ending
Dec '23 Dec '22 Dec '21
Next-generation Cell and Gene Therapies
2.56M
Log In
Log In
Next-generation Cell and Gene Therapies Growth
-40.25%
Log In
Log In

Revenue by Geography

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
FY 2023FY 2022FY 2021
Period Ending
Dec '23 Dec '22 Dec '21
United States
2.56M
Log In
Log In
United States Growth
-40.25%
Log In
Log In